Global X Funds Global X Health & Wellness ETF
BFIT
BFIT was delisted on the 16th of February, 2024.
4 hedge funds and large institutions have $1.99M invested in Global X Funds Global X Health & Wellness ETF in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
3% less capital invested
Capital invested by funds: $2.04M → $1.99M (-$53K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$117K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$14K |
BFIT Hedge Fund Activity: Q4 2017 in Review
4 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Global X Funds Global X Health & Wellness ETF (BFIT) for Q4 2017, worth a combined $1.99M — down 2.6% from $2.04M a quarter earlier.
Fund positioning in BFIT was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $1.63K. The largest seller was Susquehanna International Group, cutting an estimated $117K.
- 4 institutional investors held Global X Funds Global X Health & Wellness ETF (BFIT) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $1.99M of Global X Funds Global X Health & Wellness ETF stock for Q4 2017, down 2.6% quarter-over-quarter.
- 0 funds opened new Global X Funds Global X Health & Wellness ETF positions in Q4 2017 and 0 closed out.
- The largest Global X Funds Global X Health & Wellness ETF buyer in Q4 2017 was UBS Group, an estimated $1.63K added.
- The largest Global X Funds Global X Health & Wellness ETF seller in Q4 2017 was Susquehanna International Group, an estimated $117K sold.
Based on aggregated 13F filings for Q4 2017.